Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia

NCT07397325 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy Induced Alopecia
Chemotherapy Side Effects

Interventions

DRUG: DA-020
DRUG: Placebo
DRUG: DA-020 and Hyperforin

Sponsor

Applied Biology, Inc.

Collaborators

[object Object]
[object Object]